Advertisement

Topics

GlaxoSmithKline Presents Positive Results From Phase III Revaccination Study Of Its Candidate Shingles Vaccine Shingrix At CDC's Advisory Meeting

20:00 EDT 20 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: GlaxoSmithKline Presents Positive Results From Phase III Revaccination Study Of Its Candidate Shingles Vaccine Shingrix At CDC's Advisory Meeting

NEXT ARTICLE

More From BioPortfolio on "GlaxoSmithKline Presents Positive Results From Phase III Revaccination Study Of Its Candidate Shingles Vaccine Shingrix At CDC's Advisory Meeting"

Advertisement
Quick Search
Advertisement
Advertisement